STRATA Skin Sciences (SSKN) saw its stock price drop over 21% despite the announcement that Johns Hopkins Dermatology added the XTRAC 308 nm excimer laser to its clinical offerings. This collaboration aims to enhance precision treatment for chronic skin conditions like psoriasis and vitiligo. The adoption by Johns Hopkins, a leading academic medical center, underscores the growing importance of advanced dermatologic innovation and targeted phototherapy.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
STRATA Shares Plummet 21% as Johns Hopkins Adds Excimer Laser
STRATA Skin Sciences (SSKN) saw its stock price drop over 21% despite the announcement that Johns Hopkins Dermatology added the XTRAC 308 nm excimer laser to its clinical offerings. This collaboration aims to enhance precision treatment for chronic skin conditions like psoriasis and vitiligo. The adoption by Johns Hopkins, a leading academic medical center, underscores the growing importance of advanced dermatologic innovation and targeted phototherapy.